SLC2A3 and neoplasm: In patients with advanced laryngeal carcinomas treated with surgery, Starska et al. [14] found an increase in the transcriptional and immunohistochemical expression of SLC2A3 in tumor tissue relative to adjacent normal laryngeal tissue.